Eligibility Criteria

Component A: Ending the HIV Epidemic Initiative (EHE) – Required Core Component

Eligible applicants include state, local, and territorial health departments or their Bona Fide Agents identified in Phase 1 of the Ending the HIV Epidemic (EHE) Initiative and that have a current direct funding relationship with CDC. Eligibility for funding to implement the above described program is contingent upon the existence of a comprehensive EHE plan.

The Ending the HIV Epidemic: A Plan for America is a new initiative announced by the President in February 2019. The Phase 1 jurisdictions represent more than 50% of new HIV diagnoses in only 48 counties, Washington, DC, and San Juan Puerto Rico. In addition, seven (7) states have a substantial rural burden with over 75 cases and 10% or more of the diagnoses in rural areas.

Jurisdictions with both eligible state and local (city or county) health departments listed in the table above must collaborate on and discuss: (1) the proposed program approach being implemented by the state and local health departments, (2) how the state and local area will collaborate during the project period to ensure appropriate provision of services and document any agreements reached in a letter of agreement/letter of concurrence (LOA/LOC), which must be submitted by both parties as part of their application; and (3) ensure that fiduciary arrangements specify that the funding resources are directed towards the Phase 1 local county, as appropriate.

Component B: HIV Incidence Surveillance (Optional)- Beginning in Year 2

Eligible recipients have to meet the following criteria:

• Ending the HIV Epidemic geographic focus area with > 300 new HIV diagnoses annually
• Reliable incidence estimates from the CD4-based model
• Previous success in implementing recency assay-based HIV Incidence Surveillance
• Based on the above criteria, the following eight recipients are eligible for voluntary participation:

Component C: Scaling Up HIV Prevention Services in STD Clinics (Optional)

Only jurisdictions eligible for Component A of this NOFO, PS20-2010, can apply for Component C. Applicants must demonstrate that the proposed STD specialty clinic has the following services available onsite: STAT syphilis test, microscope for STAT Gram stain/Methylene Blue/Gentian Violet and wet mount, gonorrhea culture capacity, and medications on site including Benzathine Penicillin LA and ceftriaxone.